Reduced PHB1 expression attenuates the protection of mitochondrial function and disturbs mitochondrial oxidative stress, the oxidative phosphorylation system and the glycolytic metabolic shift, leading to cancer-like hyperproliferation phenotype, ultimately resulting in pulmonary vascular remodeling and PAH. The gene discussed is PHB1; the disease is pulmonary arterial hypertension.